National Center for Environmental Health, CDC, Atlanta, GA, USA.
Office of Dietary Supplements, NIH, Bethesda, MD, USA.
J Nutr. 2021 Aug 7;151(8):2446-2454. doi: 10.1093/jn/nxab147.
Data from the 2007-2010 NHANES suggested that vitamin D supplements contributed to increased serum concentrations of 25-hydroxyvitamin D [25(OH)D] in the US population.
We sought to determine whether 25(OH)D continued to increase during NHANES 2011-2014 and whether associations of 25(OH)D with preselected covariates differed across time periods.
For this study, 25(OH)D was measured in adults (≥20 y) using LC-MS/MS. Descriptive and regression analyses were stratified by survey period to investigate the effects of age, race-Hispanic origin, sex, season, BMI, dietary vitamin D, and vitamin D-containing supplements. A multiple linear regression model was used to assess 25(OH)D changes between two 4-y survey periods, namely 2007-2010 and 2011-2014.
We observed several significant concomitant increases between 2007-2010 and 2011-2014: unadjusted mean 25(OH)D increased by 2.7 nmol/L (95% CI: 0, 5.4 nmol/L; P = 0.048), the percentage of persons taking any vitamin D-containing supplements increased 2.9% (95% CI: 0.03, 5.5%; P = 0.0314), and the percentage of persons taking high-dose (≥1000 IU/d) vitamin D-containing supplements increased 8.6% (95% CI: 6.9, 9.9%; P < 0.0001). With covariate adjustment, the increase in 25(OH)D from 2007-2010 to 2011-2014 was no longer statistically significant [1.4 nmol/L (95% CI: -3.0, 0.23 nmol/L; P = 0.09)]. After adjustments, several large differences in 25(OH)D remained, namely non-Hispanic blacks had 25(OH)D 22 nmol/L lower than that of non-Hispanic whites, and users of vitamin D-containing supplements ≥1000 IU/d had 25(OH)D 31 nmol/L higher than that of nonusers.
After adjusting for vitamin D supplement dose, the overall adjusted increase in 25(OH)D was no longer statistically significant, suggesting that changes in US adults' 25(OH)D concentrations between NHANES periods 2007-2010 and 2011-2014 may primarily be associated with changes in vitamin D supplementation.
2007-2010 年 NHANES 的数据表明,维生素 D 补充剂可增加美国人群血清 25-羟维生素 D [25(OH)D] 浓度。
我们旨在确定 25(OH)D 在 2011-2014 年 NHANES 期间是否持续增加,以及 25(OH)D 与预先选择的协变量的相关性是否随时间而变化。
本研究采用 LC-MS/MS 法测量成年人(≥20 岁)的 25(OH)D。按调查期分层进行描述性和回归分析,以调查年龄、种族-西班牙裔来源、性别、季节、BMI、膳食维生素 D 和含维生素 D 的补充剂对 25(OH)D 的影响。采用多元线性回归模型评估两个 4 年调查期(2007-2010 年和 2011-2014 年)之间 25(OH)D 的变化。
我们观察到 2007-2010 年至 2011-2014 年间存在几个显著的同时增加:未经调整的平均 25(OH)D 增加了 2.7 nmol/L(95%CI:0,5.4 nmol/L;P = 0.048),服用任何含维生素 D 的补充剂的人数增加了 2.9%(95%CI:0.03,5.5%;P = 0.0314),服用高剂量(≥1000 IU/d)含维生素 D 的补充剂的人数增加了 8.6%(95%CI:6.9,9.9%;P < 0.0001)。在调整协变量后,2007-2010 年至 2011-2014 年期间 25(OH)D 的增加不再具有统计学意义[1.4 nmol/L(95%CI:-3.0,0.23 nmol/L;P = 0.09)]。调整后,25(OH)D 仍存在几个较大差异,即非西班牙裔黑人的 25(OH)D 比非西班牙裔白人低 22 nmol/L,而服用≥1000 IU/d 维生素 D 补充剂的人比不服用的人高 31 nmol/L。
在调整维生素 D 补充剂剂量后,25(OH)D 的总体调整后增加不再具有统计学意义,这表明美国成年人在 2007-2010 年和 2011-2014 年 NHANES 期间 25(OH)D 浓度的变化可能主要与维生素 D 补充剂的变化有关。